Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Group Processes”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01928537
What this trial is testing

Efficacy and Safety of IV Rigosertib in MDS Patients With Excess Blasts Progressing After Azacitidine or Decitabine

Who this might be right for
Myelodysplastic SyndromesRefractory Anemia With Excess BlastsChronic Myelomonocytic Leukemia+1 more
Traws Pharma, Inc. 67
Testing effectiveness (Phase 2)Study completedNCT01203631
What this trial is testing

Safety and Efficacy of NNC 0142-0000-0002 in Subjects With Moderately to Severely Active Crohn's Disease

Who this might be right for
InflammationCrohn's Disease
Janssen Research & Development, LLC 78
Not applicableEnrolling By InvitationNCT07298577
What this trial is testing

Use of Gender, Age, Alfa-fetoprotein (AFP), and Des-gamma-carboxyprothrombin (PIVKA-II) or GAAD Score in Addition to Ultrasound for Surveillance of People At-risk for Developing Hepatocellular Carcinoma in Asia in Order to Detect Early Liver Cancer

Who this might be right for
Liver CirrhosisHepatitis B, ChronicHepatitis C, Chronic+1 more
Siriraj Hospital 2,100
Testing effectiveness (Phase 2)Ended earlyNCT06035393
What this trial is testing

Assess the Efficacy and Safety of HRG2005 Inhalation in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease

Who this might be right for
Chronic Obstructive Pulmonary Disease
Jiangsu HengRui Medicine Co., Ltd. 82
Early research (Phase 1)Not Yet RecruitingNCT07793929
What this trial is testing

Evaluate the Impact of Renal Impairment on the Pharmacokinetics (PK) of Ribupatide

Who this might be right for
End Stage Renal DiseaseRenal ImpairmentObesity+1 more
Kailera 32
Large-scale testing (Phase 3)Study completedNCT03644264
What this trial is testing

PA21 Safety and Efficacy in Adult Chinese Subjects

Who this might be right for
Chronic Kidney Disease Requiring Chronic DialysisHyperphosphatemia
Vifor Fresenius Medical Care Renal Pharma 286
Large-scale testing (Phase 3)Study completedNCT00821093
What this trial is testing

Safety and Efficacy of Indacaterol Once Daily Versus Salmeterol Twice Daily in Chronic Obstructive Pulmonary Disease (COPD)

Who this might be right for
Chronic Obstructive Pulmonary Disease (COPD)
Novartis Pharmaceuticals 1,123
Testing effectiveness (Phase 2)Study completedNCT01153321
What this trial is testing

Investigation of the Effect of Oral Treatment With 100 mg AZD2423 in Subjects With Mild Chronic Obstructive Pulmonary Disease (COPD)

Who this might be right for
Chronic Obstructive Pulmonary DiseaseLung Disease
AstraZeneca 71
Large-scale testing (Phase 3)Ended earlyNCT00518687
What this trial is testing

Efficacy, Immunogenicity, and Safety of a Single Dose of V710 in Adult Patients Scheduled for Cardiothoracic Surgery (V710-003 AM2)

Who this might be right for
Staphylococcus AureusBacteremiaMediastinitis
Merck Sharp & Dohme LLC 8,031
Post-approval studies (Phase 4)UnknownNCT05480436
What this trial is testing

Immunogenicity and Safety of BBIBP-Corv Coadministered With PPV23 and IIV4 in Hemodialysis Population

Who this might be right for
HemolysisCOVID-19
China National Biotec Group Company Limited 1,200
Not applicableStudy completedNCT05022732
What this trial is testing

Polyglucosamine L112 in Overweight and Obese Subjects

Who this might be right for
Obesity
Azienda di Servizi alla Persona di Pavia 150
Early research (Phase 1)Ended earlyNCT05065463
What this trial is testing

To Assess the Pharmacokinetics, Safety, and Tolerability of AZD8233 in Participants With Chronic Kidney Disease (CKD), End Stage Renal Disease (ESRD) and Healthy Participants.

Who this might be right for
End Stage Renal Disease
AstraZeneca 3
Testing effectiveness (Phase 2)Study completedNCT02513771
What this trial is testing

Sitagliptin for Reducing Inflammation and Immune Activation

Who this might be right for
HIV-1 Infection
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 90
Large-scale testing (Phase 3)Ended earlyNCT04636814
What this trial is testing

A 52-week, Placebo- and Active- Controlled (Roflumilast, Daliresp® 500µg) Study to Evaluate the Efficacy and Safety of Two Doses of CHF6001 DPI (Tanimilast) as add-on to Maintenance Triple Therapy in Subjects With COPD and Chronic Bronchitis. (PILLAR)

Who this might be right for
Chronic Obstructive Pulmonary Disease
Chiesi Farmaceutici S.p.A. 3,973
Not applicableStudy completedNCT02696811
What this trial is testing

The Effects of Foods on Cell Damage Study

Who this might be right for
DNA DamageInflammation
Newcastle University 38
Testing effectiveness (Phase 2)Study completedNCT02986321
What this trial is testing

A 24-wk Dose Ranging Study to Evaluate the Efficacy and Safety of 4 Doses of a New PDE4 Inhibitor in Patients With COPD

Who this might be right for
Chronic Obstructive Pulmonary Disease
Chiesi Farmaceutici S.p.A. 1,130
Post-approval studies (Phase 4)Ended earlyNCT01883011
What this trial is testing

Evaluate the Efficacy and Safety of Piracetam on Aphasia After Acute Ischemic Cerebral Artery Stroke

Who this might be right for
Acute Ischaemic Middle Cerebral Artery Stroke
UCB S.A. - Pharma Sector 571
Not applicableStudy completedNCT01104909
What this trial is testing

How to Get a Better Dry Weight in End-stage Renal Disease (ESRD) Population for Improving Blood Pressure Control

Who this might be right for
Blood PressureEnd Stage Renal DiseaseHemodialysis
Universidade de Passo Fundo 100
Not applicableLooking for participantsNCT06569121
What this trial is testing

Efficacy of a Telehealth Delivered Group Lifestyle Balance for People Post Stroke (tGLB-CVA)

Who this might be right for
Stroke, AcuteStrokeStroke, Cardiovascular+2 more
Baylor Research Institute 94
Post-approval studies (Phase 4)Study completedNCT02236611
What this trial is testing

A 12-week Study to Evaluate the Efficacy and Safety of Umeclidinium 62.5 Microgram (mcg) Compared With Glycopyrronium 44 mcg in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Who this might be right for
Pulmonary Disease, Chronic Obstructive
GlaxoSmithKline 1,036
Next Page